Tenax Therapeutics earnings were -$64.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest TENX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$17.8M, up 13.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TENX reported annual earnings of -$52.6M, with 198.8% growth. The next TENX earnings date is Nov 11, 2026.
What were Tenax Therapeutics's earnings last quarter?
On TENX's earnings call on Aug 12, 2026, Tenax Therapeutics (NASDAQ: TENX) reported Q2 2026 earnings per share (EPS) of -$0.35, up 29.63% year over year. Total TENX earnings for the quarter were -$17.80 million. In the same quarter last year, Tenax Therapeutics's earnings per share (EPS) was -$0.27.
The next TENX earnings date is Nov 11, 2026. Add TENX to your watchlist to be reminded of Tenax Therapeutics's next earnings date.
Is Tenax Therapeutics profitable or losing money?
As of the last Tenax Therapeutics earnings report, Tenax Therapeutics is currently losing money. Tenax Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$64.86 million, a 106.03% increase year over year.
What was TENX's earnings growth in the past year?
As of Tenax Therapeutics's earnings date in Aug 12, 2026, Tenax Therapeutics's earnings has grown year over year. TENX earnings in the past year totalled -$64.86 million.
What are Tenax Therapeutics's earnings expectations?
The current EPS estimate for Tenax Therapeutics's earnings report in Nov 11, 2026 is -$0.35.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.